FDA · Enforcement report ·
Naropin vials recalled for hair contamination
The FDA classifies a recall of Naropin (ropivacaine) injection vials because hair was found in the product.
If you have been prescribed or received Naropin (ropivacaine hydrochloride) injection in single-dose vials, the US Food and Drug Administration says some products have hair (particulate matter) found in them.
This matters because contaminated medicine could expose you to unwanted material inside the vial.
The FDA notice was published 2026-07-29, and the affected vials were distributed nationwide in the USA.